E
Excellos
A unique full-service CDMO that pairs the collection of critical human cells and tissues with manufacturing and development services to drive innovation in the cell and gene therapy industry
About Excellos
Excellos is a contract development and manufacturing organization (CDMO) that specializes in the cell and gene therapy sector. The company provides a range of services, including the sourcing and customization of donor materials for cellular products, process development, and cGMP manufacturing of cell-based therapies for clinical trials.
Its business model is centered on providing critical manufacturing and development services to biopharmaceutical companies, helping them to advance their cell therapy candidates through the clinical trial process. By managing the complex manufacturing and supply chain, Excellos enables its clients to focus on the research and development of new therapies. The company collaborates with life science and biotech firms, such as TC BioPharm and Galapagos, to produce materials like CAR-T cells for FDA-cleared clinical studies.
Source: Dealroom company dataAt a glance
- Founded
- 2021
- Headquarters
- San Diego, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- VIVitalant
Series A1 investor entered at this stage
Telegraph Hill Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Excellos on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Excellos on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.